AgraFlora Engages Seasoned Cannabis Executive to Drive Asset Commercialization and Shareholder Value Creation

VANCOUVER, British Columbia, Feb. 27, 2020 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF), a growth oriented and diversified international cannabis company, is pleased to welcome John Fowler, founder of one of Canada’s top consumer brands 7ACRES and former President and CEO of the Supreme Cannabis Company, Inc. (TSX: FIRE) from 2014 to 2019.  John Fowler is the principal of Blaise Ventures Inc., a full-service consulting firm that has been engaged by the Company to support the execution of its strategic priorities to license, operationalize and solidify a path to profitability for the Company’s key assets including: Propagation Services Canada (“PSC”), Edibles & Infusions Corporation (“Edibles & Infusions”), AAA Heidelberg Inc. (“AAA”) and Farmako GmbH (“Farmako”).  John and his team will further assist AgraFlora’s management team in identifying, evaluating and executing on accretive corporate opportunities including potential acquisitions, dispositions or new revenue channels in domestic or international markets.

“I entered 2020 looking for strong assets in the cannabis industry where I felt that our team could contribute to building strong and sustainable businesses, with a focus on engaging with key consumer segments to drive profitability and return on investment for shareholders,” said John Fowler, Principal of Blaise Ventures.  “I spent the latter part of 2019 meeting with a wide range of cannabis companies throughout Canada, and was particularly impressed by AgraFlora’s market opportunity, which is further amplified by its key assets.  Properly aligned, the Company’s assets are well positioned in 2020 to transform from development projects into customer-focused businesses that fill unmet Canadian consumer demand in true commercial cannabis edible production, high potency low cost cannabis flower, and craft cannabis.  In addition, I saw an important International segment in the Farmako subsidiary which presents a great opportunity to organically scale one of Germany’s leading medical cannabis distributors into a leading distributor of medical cannabis for all of Europe.”